Pamela Kunz, MD, Leader of Gastrointestinal Cancers Program at Smilow
We are very pleased to announce the appointment of Pamela L. Kunz, MD, as Leader for the Gastrointestinal Cancers Program at Smilow Cancer Hospital and Yale Cancer Center and Director of GI Medical Oncology within the Section of Medical Oncology.
Yale Cancer Center and Yale School of Public Health Receive Grant to Fund Innovative Research Training Program
The National Institutes of Health has awarded a National Research Service Award Training Grant to fund an innovative, multidisciplinary, and translational training program at Yale Cancer Center and Yale School of Public Health.
Video: Xavier Llor, MD, PhD, on Colorectal Cancer: Why Are More Younger People Being Affected?
Xavier Llor, MD, PhD, of Yale University School of Medicine, discusses the steep rise of early-onset colorectal cancer over the past 15 years, which cannot be explained by genetic predisposition but may be prompted by environmental factors (Session ED35).Source: The ASCO Post
An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research
CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a $225,000 Young Investigator grant to Yale Cancer Center’s Dr. Ranjithmenon Muraleedharan, who will develop a new treatment approach for diffuse intrinsic pontine glioma (DIPG) – a devastating brain cancer with a 5-year survival rate of less than 1%. The 3-year project is funded by SebastianStrong Foundation’s Discovery Science Award.Source: CureSearch for Children's Cancer
Immune System Variation Can Predict Severe COVID-19 Outcomes
The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease, according to a new study by Yale Cancer Center researchers published July 27 in the journal Nature.
In Vermont, Closer To Free Ride Is Close to Home
When Stevie Hovey thinks about her dad, she says he was big: in personality, family and fun. “He was a big sailor, he spent a lot of time at the yacht club, he spent a lot of time with all of us,” said Hovey. In 2010, the 83-year-old dad and grandfather was one of the early patients at Smilow Cancer Hospital.Source: NBC Connecticut
Physician Spotlight: Dr. Julius Chapiro
Originally from Berlin, Germany, I completed major portions of my post-graduate training in the United States. I first came here as a research student in 2009 and worked on my thesis within the Department of Rheumatology and Immunology at the Yale School of Medicine in New Haven.Source: The Society of Interventional Radiology (SIR)
Marcella Nunez-Smith, MD, MHS, Named Director of Center for Community Engagement and Health Equity for Yale Cancer Center and Smilow Cancer Hospital
Marcella Nunez-Smith, MD, MHS, has been appointed Director of the Center for Community Engagement and Health Equity for Yale Cancer Center and Smilow Cancer Hospital, as well as Chief Health Equity Officer & Deputy Chief Medical Officer, at Smilow Cancer Hospital, and Associate Cancer Center Director for Community Outreach and Engagement at Yale Cancer Center.
ACA Medicaid Expansion Increases Earlier Diagnosis for Breast Cancer
Researchers at Yale Cancer Center found the average rate of uninsured breast cancer patients dropped in expansion states, with subsequent decreases in the number diagnosed with advanced cancers. No changes were found in either of these rates in non-expansion states.Source: DotMed
Yale Researchers Tackle COVID-19 and Learn from Patients with Cancer
Across Yale Cancer Center this spring, most research labs shut down to protect their personnel from COVID-19. To protect patients, clinical trial enrollment also took a two month pause. But several of our researchers with relevant expertise have continued to conduct critical research on SARS-CoV-2, the deadly new coronavirus that causes COVID-19.